Effects of Dietary Interventions on Depressive Symptom Profiles: Results from the MooDFOOD Depression Prevention Study
Overview
Authors
Affiliations
Background: Dietary interventions did not prevent depression onset nor reduced depressive symptoms in a large multi-center randomized controlled depression prevention study (MooDFOOD) involving overweight adults with subsyndromal depressive symptoms. We conducted follow-up analyses to investigate whether dietary interventions differ in their effects on depressive symptom profiles (mood/cognition; somatic; atypical, energy-related).
Methods: Baseline, 3-, 6-, and 12-month follow-up data from MooDFOOD were used (n = 933). Participants received (1) placebo supplements, (2) food-related behavioral activation (F-BA) therapy with placebo supplements, (3) multi-nutrient supplements (omega-3 fatty acids and a multi-vitamin), or (4) F-BA therapy with multi-nutrient supplements. Depressive symptom profiles were based on the Inventory of Depressive Symptomatology.
Results: F-BA therapy was significantly associated with decreased severity of the somatic (B = -0.03, p = 0.014, d = -0.10) and energy-related (B = -0.08, p = 0.001, d = -0.13), but not with the mood/cognition symptom profile, whereas multi-nutrient supplementation was significantly associated with increased severity of the mood/cognition (B = 0.05, p = 0.022, d = 0.09) and the energy-related (B = 0.07, p = 0.002, d = 0.12) but not with the somatic symptom profile.
Conclusions: Differentiating depressive symptom profiles indicated that food-related behavioral interventions are most beneficial to alleviate somatic symptoms and symptoms of the atypical, energy-related profile linked to an immuno-metabolic form of depression, although effect sizes were small. Multi-nutrient supplements are not indicated to reduce depressive symptom profiles. These findings show that attention to clinical heterogeneity in depression is of importance when studying dietary interventions.
Immuno-metabolic depression: from concept to implementation.
Penninx B, Lamers F, Jansen R, Berk M, Khandaker G, De Picker L Lancet Reg Health Eur. 2025; 48():101166.
PMID: 39801616 PMC: 11721223. DOI: 10.1016/j.lanepe.2024.101166.
Lam A, Piya M, Foroughi N, Mohsin M, Chimoriya R, Kormas N Nutrients. 2024; 16(7).
PMID: 38613100 PMC: 11013199. DOI: 10.3390/nu16071068.
A network analysis of depressive symptoms and metabolomics.
Rydin A, Milaneschi Y, Quax R, Li J, Bosch J, Schoevers R Psychol Med. 2023; 53(15):7385-7394.
PMID: 37092859 PMC: 10719687. DOI: 10.1017/S0033291723001009.